Hypoglycemia in 42%, tonsillar hypertrophy in 15%, intracranial hypertension in 3 subjects
(9) A Heinen, R Nederlof, P Panjwani, et al (2018) IGF1 Treatment Improves Cardiac Remodeling after Infarction by Targeting Myeloid Cells Molecular Therapy, 2018 Nov 1, Volume 27 (Issue 1), Pages 4658
Nature 472 (7341), 4041 (2011)
Exendin 4 is a long-acting GLP-1 receptor agonist
Your provider will evaluate your symptoms and recommend next steps
Hypoglycemia (when combined with insulin/sulfonylureas) Cagrilintide alone does not increase insulin secretion and has low intrinsic hypoglycemia risk